Solis BioDyne announces new assay kit to detect Omicron

We have started this year strong by launching SOLIScript® SARS-CoV-2 RT-qPCR Multiplex Assay Kit on the market. So far it has been confirmed to detect Omicron (B.1.1.529) with 100% detection rate.

Since the start of the pandemic we have put a lot of care into developing the most efficient tools, so that everybody could accelerate their RT-qPCR testing to combat all the COVID-19 variants. When Omicron was designated as a variant of concern by WHO on the 26th of November it was quickly confirmed that Solis BioDyne’s very own IVD grade reagent SOLIScript® 1-step CoV Kit will not be tricked by the various mutations. 

Now with the new SOLIScript® SARS-CoV-2 RT-qPCR Multiplex Assay Kit, which is currently for Research Use Only, it is possible to take testing even further. This product is based on SOLIScript® 1-step CoV Kit, but in addition supplied with all the primers, probes and positive control needed for SARS-CoV-2 detection. There is also proof from our partner diagnostic laboratory that it can detect Omicron (B.1.1.529) from clinical samples with 100% detection rate. Furthermore, the kit is 100% in agreement with LDT and Seegene CE-IVD kit. 

Contact the experts at

Read more about our products to improve your SARS-CoV-2 testing: